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This study evaluated the influence of glucose and stirring in the fermentation process in order to 
produce anti-Candida metabolites produced by Streptomyces sp. MPO4 isolated from Amazon soil. 
The anti-Candida metabolites production was registered after 24 h of fermentation in stirred ISP2 
medium, having antifungal inhibition halos between 12.3 mm and 25.3 mm, yielding higher production 
of anti-Candida agents after 96 h. Stirring was a determining factor for the production of anti-Candida 
secondary metabolites, since the absence of glucose reflected in the late production of the antifungal 
starting from Streptomyces sp. 
Uniterms: Streptomyces sp./anti-Candida activity. anti-Candida metabolites/production. Fermentation.
Este estudo avaliou a influência da glicose e agitação no processo de fermentação para a produção de 
metabólitos anti-Candida produzidos por Streptomyces sp. MPO4 isolado do solo da Amazônia. A 
produção dos metabólitos anti-Candida foi registrada a partir de 24 h de fermentação sob agitação em 
meio ISP2, apresentando halos de inibição entre 12,3 mm e 25,3 mm, obtendo-se maior produção do 
antifúngico em 96 h. A agitação foi um fator determinante para a produção de metabólitos secundários 
anti-Candida e a ausência de glicose refletiu na produção tardia do antifúngico a partir do Streptomyces sp.
Unitermos: Streptomyces sp./atividade anti-Candida. Metabólitos anti-Candida/produção. Fermentação.
INTRODUCTION
The bioactive compounds of microbial origin are 
produced by specific groups of bacteria and eukaryotic 
microorganisms such as Actinomycetes, Themyxobacteria, 
Pseudomonas and the Cyanobacteria and most of 
filamentous fungi.
Actinobacteria are Gram-positive filamentous 
bacteria group with high capacity to produce several 
secondary metabolites (Jørgensen et al., 2010; Karuppiah 
et al., 2013; Prakash et al., 2013; Kim, Yang, Yoon, 2015). 
They are usually isolated from soil consisting in about 30% 
of the microbial population (Goodfellow, Fiedler, 2010). 
In this group the Streptomyces genus are widely studied 
for its abilities to produce bioactive compounds used in 
the synthesis of about 70% of the antibiotics of choice in 
the treatment of microbial infections (Lacaz et al., 2002; 
Kim et al., 2012; Rashad et al., 2015) and 60% are used 
in agriculture. 
Actinomycetes may be exist in various habitats such 
as water, soil and plants, which are estimated for each gram 
of soil there are about 106 - 109 Colony Forming Units 
(CFU) by actinomycetes. Its wide distribution is justified 
because these bacteria are not very demanding in terms of 
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the substrate for growth, as they are described autotrophic 
genres, heterotrophic, chemotrophic or phototrophic 
(González et al., 2005).
In addition to antibiotics, metabolites related with 
the following activities: anti-inflammatory, antiparasitic, 
antiviral, antiprotozoal, immunomodulators, antitumor 
(Kim et al., 2012; Karuppiah et al., 2013; Manivasagan 
et al., 2014; Rashad et al., 2015) and vitamins (Shin et al., 
2007; Arumugam et al., 2010) have also been isolated by 
fermentation processes of these bacteria (Manivasagan et 
al., 2014; Rashad et al., 2015).
This secondary metabolites is obtained by 
fermentative processes. The nature and concentration 
of nutrients in the medium such as carbon, nitrogen, 
phosphorus and minerals as well as the essential substances 
for biosynthetic pathway can promote the production of 
larger quantities of one or another compound inferring 
directly on its performance (Gupte, Kulkarni, 2002; Chen 
et al., 2012; El-Naggar et al., 2015).
Among the external factors with influence at the 
biosynthesis of secondary metabolites by microorganisms, 
the sources of carbon and nitrogen are highly relevant, 
since they are related to both substrate availability for 
the synthesis of metabolites as to the modulation of the 
enzymatic process and may activate and stabilize the 
enzymes involved in the process (Gupte, Kulkarni, 2002; 
El-Naggar et al., 2015).
Sugars such as glucose are routinely used as a 
carbon source for the growth and secondary metabolite 
production during fermentation. However, the production 
of some metabolites is suppressed by the inhibition of any 
enzyme involved in the process and consequently leads to 
activation of other metabolic pathways (El-Naggar et al., 
2015; Sanchez, Quintero, Ochoa, 2015).
Both stirring or aeration favors the development of 
primary metabolism of aerobic microorganisms, especially 
during the multiplication stage, thus favoring the complete 
transformation of the sources of carbohydrates present in 
the fermentation medium (Muller et al., 2007). 
The search for new bioactive compounds especially 
those with effective antimicrobial compounds against 
multiresitent microorganisms as Candida species can 
contribute to the control of this microorganism commonly 
associated with nosocomial infections. The increasing 
incidence of multidrug-resistant organisms is a major 
public health problem, especially Candida albicans, 
which although it is considered a commensal inhabitant of 
various parts of the body, particularly the gastrointestinal 
and genital tract, is associated with many cases of hospital 
infection, including the ability to promote primary 
infections in immunocompromised patients. (Avrella, 
Goulart, 2008; Giolo, Svidzinski, 2010). 
This study evaluated the influence of the glucose 
presence and stirring to produce compounds with anti-
Candida activity produced by Streptomyces sp. MPO-4 
isolated from rhizosphere soil of Amazon.
MATERIAL AND METHODS
Streptomyces sp. MPO4 strain
The Streptomyces sp. MPO-4 used in this study was 
obtained from the collection of the culture of Microbiology 
Laboratory of the Federal University of West Para. The 
lineage is a rhizosphere actinomycete from the tree Aniba 
parviflora syn A. fragans (Macacaporanga) and was 
isolated from the transition area between dense forest and 
savanna in the Amazon rainforest (2028’S and 54049’W) 
in Santarém - PA (Figure 1).
The Streptomyces sp. MPO4 was isolated on Agar 
Yeast Arginine medium (AYA: 0.3 g L-arginine, 1 g 
glucose, 1 g glycerol, 0.3 g K2HPO4, 0.2 g MgSO4.7H2O, 
0.3 g NaCl, 1 g yeast extract, 1 mL Salt Solution [0.1 g 
FeSO4.7H2O, 0.1 g MnCl2.4H2O, 0.1 g ZnSO4.7H2O, 
100 mL distilled water, pH 7.0-7.4], 17 g agar, 1000 mL 
distilled water, pH 6.4) (Nonomura, Ohara, 1969) plus 
nystatin (100 µg/mL) at 30 °C for 14 days from the serial 
dilution (10-3, 10-4 e 10-5 CFU/mL) of 10 g soil adhered 
to the plant root in 90 mL of phosphate buffer. The 
morphological identification was made through evaluation 
of cultural characters and micromorphology (Williams, 
Sharpe, Holt, 1989).
Anti-Candida activity
Streptomyces sp. MPO-4 was grown on ISP2 
medium (International Streptomyces Project: 4 g yeast 
extract, 10 g malt extract, 4 g glucose, 15 g agar, 1000 
mL distilled water, pH 7.2) (Shirling, Gottlieb, 1966) in 
Petri dish (60 × 15 mm) incubated at 30 ºC for 168 hours 
for sporulation and colonization of the entire surface of 
the culture medium.
The evaluation of the anti-Candida activity of 
Streptomyces sp. MPO4 was initially performed by the 
method of agar block (Ichikawa et al., 1971) against 
Candida albicans (UFPEDA1007) starting from agar 
blocks of 6 mm in diameter containing Streptomyces 
sp. MPO4 cultures grown for 14 days at 30 °C in dish 
plates containing Sabouraud Glucose Agar (SDA) (20 g 
glucose, 5 g pepitic digest of animal tissue, 5 g pancreatic 
digest of casein, 15 g agar, 1000 mL distilled water, pH 
5.6) previously inoculated with the Candida suspension 
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adjusted to 0.5 McFarland. The plates were maintained at 
30 °C and for 48 h to observe the inhibition halo.
It was adopted a completely randomized design with 
4 replications. Data were subjected to analysis of variance 
and means compared by Tukey test with 5% of probability. 
Intensity of the inhibitory activity was classified 
according to Sahin and Ugur (2003), and the size of the 
inhibition zone divided into four different groups: group 
ability-zone of inhibition less than 10 mm; slightly active 
group-inhibition zone between 11 and 20 mm; moderately 
active group-inhibition zone between 21.2 mm and 
30 mm; and highly active group, whose zone of inhibition 
is greater than 31 mm.
Fermentation
After anti-Candida’s activity screening, was carried 
submerged fermentation in 250 mL erlenmeyer flask using 
the ISP2 medium from 50 mL of the pre-inoculum kept 
under stirring of 180 rpm (Magnetic stirrer Fisatom® 
Mode l751) for 48 h at room temperature (Braga et al., 
1967). An aliquot of 10% of the pre-inoculum was used 
for fermentation in ISP2 medium with 4% dextrose and 
ISP2 modified by removal of dextrose. The fermentation 
occurred both under agitation of 180 rpm for 168 h and 
without stirring. The anti-Candida activity, temperature, 
pH and weight of the biomass were monitored every 24 h 
(Braga et al., 1967).
To evaluate the anti-Candida activity to every 24 h 
the fermented liquid was centrifuged (927 g, 10 minutes) 
to precipitate the biomass and 100 µL of the supernatant 
were used on the test by the diffusion method in wells 
(Thakur et al., 2009) in Petri dishes containing Sabouraud 
Glucose Agar (SDA) previously inoculated with the 
Candida albicans suspension. The plates were incubated 
at 30 °C for 48 h and the antifungal activity was detected 
by the presence of zones of inhibition in millimeters. 
It was adopted a completely randomized design with 4 
replications. Data were subjected to analysis of variance 
and means compared by Tukey test at 5% probability.
FIGURE 1 - Map of geographic coordinates of the soil sampling point rhizosphere of Aniba parviflora syn A. fragans (Macacaporanga) 
(Latitude 20 28 ‘01.28 “S Longitude 540 49’ 45.32).
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The quantification of wet biomass was done by 
centrifuging the fermented liquid (927 g, 20 min) in 
falcon cones with their weight previously measured. 
Subsequently, it was removed the supernatant and it was 
measured the weight of biomass that remained at the 
falcon cone.
Obtaining metabolites
The fermented liquid was filtered through cellulose 
acetate 0.22 µm porosity filter and the filtrate was subjected 
to extraction of secondary metabolites using ethyl acetate 
for 3 steps at a ratio (2:1) under mechanical stirring for 
1 h at 180 rpm. The organic phase was concentrated on a 
rotary evaporator to obtain the crude extract.
RESULTS
The anti-Candida activity of fermented liquid in 
ISP2 medium varied according to fermentation time, 
showing growth inhibition zones of between 12.3 mm 
and 25.3 mm. These activities are therefore classified as 
moderately active and slightly active, respectively (Table I).
Inhibition zones were registered only in the 
metabolic liquid after a 24 h fermentation process. In 96 h, 
the production of anti-Candida metabolites was increased. 
The zones of inhibition for Candida albicans can be seen 
in Figure 2.
Stirring was a determining factor for the production 
of antifungal secondary metabolites, but was not 
significant for the production of biomass (Figure 3).
Carbon source was an important factor in the 
production of anti-Candida metabolites, and the presence 
of glucose optimizes the production of metabolites in 
shorter fermentation, with production of antifungal 
metabolites in the fermentation liquid in ISP2 modified 
stirring from 96 h fermentation. The carbon source 
influenced positively also in the production of biomass.
DISCUSSION
The ISP2 medium proved to be a good alternative 
for the generation of bioactive metabolites with antifungal 
activity by submerged fermentation (Cunha et al., 2009). 
Analyzing the fermentation process in different culture 
media of endophytic strain Streptomyces sp. EBR-49 
UFPEDA isolated from plant roots Conyza bonariensis 
(L.), it was observed that the largest zones of inhibition 
were against Bacillus subtilis ATCC 6633 in ISP2 medium, 
concluding that this is the best medium for the production 
of bioactive compound for that lineage.
 Also,  i t  was  evaluated the  product ion of 
antimicrobial metabolites testing different culture medium 
for fermentation which achieved better inhibition halo 
from the fermented liquid 72 h at ISP2 with (4%) carbon 
source (glucose) and recorded growth inhibition zones 
24.5 mm at 72 h of fermentation.
Carbon source and the aeration development of 
primary metabolism resulting in increased biomass and 
interferes with antibiotic production by the suppression 
of the biosynthetic enzymes (Muller et al., 2007; Demain, 
Sanchez, 2009). In this study the carbon source interferes 
on late production of anti-Candida metabolites and 
stirring was a determinate factor of antibiotic metabolites 
production.
Therefore, the selection of culture media is essential 
during the process of production of antibiotics by 
microorganisms. Since, microbial growth this not directly 
related to the production of antimicrobial metabolites. Thus 
a microorganism can grow without producing metabolites 
with this property, thus resulting in a significant amount of 
biomass and allows yield of bioactive metabolites. Thakur 
et al. (2009) observed during fermentation of Streptomyces 
sp. 201 that the antimicrobial activity of the fermented 
liquid was not related to biomass amount.
Salamoni (2009) described the antimicrobial 
activity obtained from the fermentation of 25 species of 
TABLE I - Mean values of halos of inhibition of Candida albicans growth compared to the different liquid fermented
Fermentation time ISP2 With stirring
ISP2 
Without stirring
ISP2 Modified 
With stirring
ISP2 Modified 
Without stirring
24 h 12.3 ± 0.58aF - - -
48 h 15.3 ± 0.58aE - - -
72 h 21.3 ± 0.58aC - - -
96 h 25.3 ± 0.58aA - 24.3 ± 0.58aA -
120 h 24 ± 1.73aAB - 23 ± 1aA -
144 h 23 ± 1aB - 19.3 ± 0.58bB -
168 h 19.3 ± 0.58aD - 13.3 ± 1bC -
Same letters are not statistically different by Tukey test (p < 0.05)
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FIGURE 2 - Anti-Candida activity of fermented liquid Streptomyces sp. MPO-4 against Candida albicans. A) Fermented liquid 
ISP2 without stirring; B) Fermented liquid ISP2 with stirring; C) Fermented liquid ISP2 modified with stirring; D) Fermented 
liquid ISP2 modified without stirring.
FIGURE 3 - Growth of biomass vs time in different fermentation conditions.
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actinomycetes of the genus Streptomyces using mineral 
medium of casein and starch, and ISP2 medium, where 
80% of the isolates were able to inhibit at least one of the 
tested bacteria. In another study, Salamoni, Van der Sand 
and Germani (2012) gave better yield of antimicrobial 
metabolites by the fermentation of Streptomyces sp.1S 
on ISP2 medium at 28 °C by the 24 h of fermentation, by 
being active against Gram-positive and Gram-negative 
bacteria, and even yeasts such as Candida albicans and 
filamentosus fungi.
CONCLUSION
Streptomyces  sp. MPO-4 isolated from the 
rhizosphere soil of Aniba parviflora Syn A. fragans 
(Macacaporanga) produces anti-Candida metabolites with 
increased activity in fermentation in ISP2 medium with 
glucose and stirring, having inhibition halos between 12.3 
mm and 25.3 mm, yielding higher production of antifungal 
agents after 96 h. Stirring was a determining factor for the 
production of anti-Candida secondary metabolites, since 
the absence of glucose reflected in the late production of 
the anti-Candida metabolites.
B iop rospec t ing  o f  mic roo rgan i sms  wi th 
biotechnological potential has enabled the use of 
bioactive compounds in several areas of knowledge, and 
the isolation of actinomycetes present in differentiated 
soil such as the Amazon as well as the elucidation of 
compounds bioactive, represent the primary goal for this 
research group, presenting this way, as a possibility of 
local scientific development generating immediate impact 
for the pharmaceutical, food industry, environmental and 
cosmetology, thereby resulting in social and economic 
development of the Amazon.
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